MAGNETIC-RESONANCE-IMAGING OF THE HEPATOBILIARY SYSTEM - INTESTINAL-ABSORPTION STUDIES OF MANGANESE MESOPORPHYRIN

被引:10
作者
SCHMIEDL, UP
NELSON, JA
TENG, L
STARR, F
MALEK, R
HO, RJY
机构
[1] BIOPATH LABS,REDMOND,WA
[2] UNIV WASHINGTON,SCH PHARM,DEPT PHARMACEUT,SEATTLE,WA 98195
关键词
MAGNETIC RESONANCE IMAGING; LIVER; MANGANESE MESOPORPHYRIN;
D O I
10.1016/S1076-6332(05)80702-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rationale and Objectives. We studied the intestinal absorption of manganese mesoporphyrin (Mn-mesoporphyrin), a potential oral hepatobiliary contrast agent. Methods. Mn-mesoporphyrin was complexed with monoolein and taurocholate (mixed micelles). Portal venous delivery and biliary excretion were measured after intestinal administration in rats and rabbits, and the mechanism of intestinal transport was studied in a combined lymph-bile fistula model in rats. T1-weighted magnetic resonance (MR) images of the liver were obtained in rats and domestic pigs before and after gastric administration of Mn-mesoporphyrin in mixed micelles. Results. A 2.2-fold increase of portal venous Mn con centration was found 90 min after intestinal administration of the complex. None was found in the lymph collected from the thoracic duct, indicating a transcellular transport mechanism through the intestinal mucosa with portal venous delivery. Mn-mesoporphyrin levels in bile peaked bem een 240 and 270 min after administration (200-fold increase). The greatest liver enhancement (20-90%) was measured 360 min after administration. Conclusion. The feasibility of intestinal delivery of Mn-mesoporphyrin, a lipophilic hepatobiliary contrast agent, was demonstrated.
引用
收藏
页码:994 / 1001
页数:8
相关论文
共 13 条
[1]   HEPATIC MR IMAGING WITH MN-DPDP - SAFETY, IMAGE QUALITY, AND SENSITIVITY [J].
BERNARDINO, ME ;
YOUNG, SW ;
LEE, JKT ;
WEINREB, JC .
RADIOLOGY, 1992, 183 (01) :53-58
[2]  
GAD SC, 1994, SAFETY ASSESSMENTS P, P243
[3]   MR IMAGING OF THE GASTROINTESTINAL-TRACT - VALUE OF GD-DTPA [J].
LANIADO, M ;
KORNMESSER, W ;
HAMM, B ;
CLAUSS, W ;
WEINMANN, HJ ;
FELIX, R .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1988, 150 (04) :817-821
[4]   PHARMACOKINETICS OF SUPERPARAMAGNETIC IRON-OXIDE MR CONTRAST AGENTS IN THE RAT [J].
MAJUMDAR, S ;
ZOGHBI, SS ;
GORE, JC .
INVESTIGATIVE RADIOLOGY, 1990, 25 (07) :771-777
[5]  
MURANISHI S, 1990, CRIT REV THER DRUG, V7, P1
[6]   FORMULATION OF RADIOGRAPHICALLY DETECTABLE GASTROINTESTINAL CONTRAST AGENTS FOR MAGNETIC-RESONANCE-IMAGING - EFFECTS OF A BARIUM-SULFATE ADDITIVE ON MR CONTRAST AGENT EFFECTIVENESS [J].
RUBIN, DL ;
MULLER, HH ;
YOUNG, SW .
MAGNETIC RESONANCE IN MEDICINE, 1992, 23 (01) :154-165
[7]   ABSORPTION OF OLEIC ACID IN BILE FISTULA RAT [J].
SAUNDERS, DR ;
DAWSON, AM .
GUT, 1963, 4 (03) :254-+
[8]  
SCHMIEDL U, 1993, INVEST RADIOL, V10, P925
[9]   HEPATIC CONTRAST-ENHANCING PROPERTIES OF MANGANESE-MESOPORPHYRIN AND MANGANESE-TPPS4 - A COMPARATIVE MAGNETIC-RESONANCE-IMAGING STUDY IN RATS [J].
SCHMIEDL, UP ;
NELSON, JA ;
STARR, FL ;
SCHMIDT, R .
INVESTIGATIVE RADIOLOGY, 1992, 27 (07) :536-542
[10]  
SCHUHMANNGIAMPI.G, 1992, RADIOLOGY, V183, P59